Cargando…

Residual endogenous insulin secretion in Japanese children with type 1A diabetes

We investigated serum C-peptide immunoreactivity (CPR) levels in registered data from a multi-center collaborative nationwide type 1 diabetes study. The CPR levels were obtained from 576 and 409 children during the early registration (2013/2014) and late observation (2016/2017) periods, respectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sugihara, Shigetaka, Kikuchi, Toru, Urakami, Tatsuhiko, Yokota, Ichiro, Kikuchi, Nobuyuki, Kawamura, Tomoyuki, Amemiya, Shin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society for Pediatric Endocrinology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783123/ https://www.ncbi.nlm.nih.gov/pubmed/33446949 http://dx.doi.org/10.1297/cpe.30.27

Ejemplares similares

The glycemic control has improved in Japanese patients with childhood-onset type 1 diabetes mellitus since 1995
por: Amemiya, Shin, et al.
Publicado: (2015)

Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit
por: Sugihara, Shigetaka, et al.
Publicado: (2019)

Chromosome 6q24 methylation defects are uncommon in childhood-onset non-autoimmune diabetes mellitus patients born appropriate- or large-for-gestational age
por: Okuno, Misako, et al.
Publicado: (2016)

Nucleotide substitutions in CD101, the human homolog of a diabetes susceptibility gene in non‐obese diabetic mouse, in patients with type 1 diabetes
por: Okuno, Misako, et al.
Publicado: (2016)

Changes in Glycemic Control and Quality of Life in Pediatric Type 1 Diabetics with Continuous Subcutaneous Insulin Infusion of Insulin Aspart Following Multiple Daily Injection Therapy
por: Kawamura, Tomoyuki, et al.
Publicado: (2008)

A case report with functional characterization of a HNF1B mutation (p.Leu168Pro) causing MODY5
por: Yoshida, Kei, et al.
Publicado: (2021)

Insulin Resistance during Puberty in Non-obese Japanese Children
por: Morimoto, Shigeo, et al.
Publicado: (2011)

Clinical characteristics in Japanese children with nonobese type 2 diabetes
por: Urakami, Tatsuhiko
Publicado: (2018)

Increasing secular trends in height and obesity in children with type 1 diabetes: JSGIT cohort
por: Mochizuki, Mie, et al.
Publicado: (2020)

Relation between Delayed Superfluous Insulin Secretion during An Oral Glucose Tolerance Test and Metabolic Disorders in Obese Japanese Children
por: Sato, Hidetoshi, et al.
Publicado: (2011)

Insulin glargine in pediatric patients with type 1 diabetes in Japan
por: Urakami, Tatsuhiko, et al.
Publicado: (2014)

Survey of Current Medical Treatments for Childhood-Onset Type 2 Diabetes Mellitus in Japan
por: Sugihara, Shigetaka, et al.
Publicado: (2005)

Relatively Small Birth Size and Accelerated Early Growth of Japanese Type 1 Diabetic Children with Younger Onset
por: Kotani, Yumiko, et al.
Publicado: (2006)

TYK2 Promoter Variant Is Associated with Impaired Insulin Secretion and Lower Insulin Resistance in Japanese Type 2 Diabetes Patients
por: Mori, Hitoe, et al.
Publicado: (2021)

Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin
por: Miya, Aika, et al.
Publicado: (2021)

Adiponectin, ALT and family history as critical markers for the development of type 2 diabetes in obese Japanese children
por: Yasuda, Yuki, et al.
Publicado: (2020)

Effect of Endogenous GLP-1 on Insulin Secretion in Type 2 Diabetes
por: Salehi, Marzieh, et al.
Publicado: (2010)

Fasting tests of insulin secretion and sensitivity predict future prediabetes in Japanese with normal glucose tolerance
por: Onishi, Yukiko, et al.
Publicado: (2010)

Efficacy and safety of switching to insulin glulisine from other rapid-acting insulin analogs in children with type 1 diabetes
por: Urakami, Tatsuhiko, et al.
Publicado: (2015)

Undercarboxylated osteocalcin correlates with insulin secretion in Japanese individuals with diabetes
por: Funakoshi, Shogo, et al.
Publicado: (2020)

Treatment for Childhood Type 2 Diabetes
por: Urakami, Tatsuhiko
Publicado: (2005)

Endogenous insulin secretion in critically ill patients
por: Pretty, C, et al.
Publicado: (2012)

The Advanced Diabetes Technologies for Reduction of the Frequency of Hypoglycemia and Minimizing the Occurrence of Severe Hypoglycemia in Children and Adolescents with Type 1 Diabetes
por: Urakami, Tatsuhiko
Publicado: (2023)

The Characteristics Of Abdominal Fat Distribution In Japanese Adolescents With Type 2 Diabetes Mellitus
por: Abe, Yuriko, et al.
Publicado: (2019)

Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin
por: Jones, Angus G, et al.
Publicado: (2012)

Basal insulin requirement of youth with type 1 diabetes differs according to age
por: Urakami, Tatsuhiko, et al.
Publicado: (2013)

Japanese Registry of Neuroendovascular Therapy: Extracranial Steno-occlusive Diseases except for Internal Carotid Artery Stenosis
por: KIKUCHI, Takayuki, et al.
Publicado: (2014)

New insights into the pharmacological treatment of pediatric patients with type 2 diabetes
por: Urakami, Tatsuhiko
Publicado: (2018)

Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment
por: Urakami, Tatsuhiko
Publicado: (2019)

Juvenile case with the coexistence of maturity‐onset diabetes of the young 1 and later‐onset latent autoimmune diabetes in youth
por: Yoshida, Kei, et al.
Publicado: (2020)

Increased trend in the incidence of diabetes among youths in the USA during 2002–2012
por: Urakami, Tatsuhiko
Publicado: (2017)

Severe Hypoglycemia: Is It Still a Threat for Children and Adolescents With Type 1 Diabetes?
por: Urakami, Tatsuhiko
Publicado: (2020)

Association of birthweight with diabetes and insulin sensitivity or secretion in the Japanese general population
por: Oya, Junko, et al.
Publicado: (2015)

Case of type 2 diabetes possibly caused by excessive accumulation of visceral fat in a child born small‐for‐gestational age
por: Kuwabara, Remi, et al.
Publicado: (2020)

Longitudinal changes in insulin sensitivity, insulin secretion, beta cell function and glucose effectiveness during development of non-diabetic hyperglycemia in a Japanese population
por: Aizawa, Toru, et al.
Publicado: (2014)

Treatment strategy for children and adolescents with type 2 diabetes-based on ISPAD Clinical Practice Consensus Guidelines 2022
por: Urakami, Tatsuhiko
Publicado: (2023)

Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance
por: Kozawa, Junji, et al.
Publicado: (2012)

Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity
por: Kozawa, Junji, et al.
Publicado: (2012)

Pediatric hypertension based on Japanese Society of Hypertension Guidelines (JSH 2019) with actual school blood pressure screening data in Japan
por: Kikuchi, Toru
Publicado: (2021)

The Role of Endogenous Incretin Secretion as Amplifier of Glucose-Stimulated Insulin Secretion in Healthy Subjects and Patients With Type 2 Diabetes
por: Woerle, Hans Juergen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_naut72mpmsekhfe7brriomc9af